BONUS CAP-ZERTIFIKAT - ROCHE GS Share Price

Certificat

DE000VM75XP8

Real-time Boerse Frankfurt Warrants 05:32:11 24/06/2024 pm IST
303.2 EUR +0.10% Intraday chart for BONUS CAP-ZERTIFIKAT - ROCHE GS
Current month+9.30%
1 month+8.76%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24/24/24 303.2 +0.10%
21/24/21 302.9 +0.32%
20/24/20 301.9 -0.41%
19/24/19 303.2 +0.45%
18/24/18 301.8 +0.94%

Real-time Boerse Frankfurt Warrants

Last update June 24, 2024 at 05:32 pm IST

More quotes

Static data

Product typeCertificats Bonus
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WKN VM75XP
ISINDE000VM75XP8
Date issued 08/01/2024
Strike 300 CHF
Maturity 20/12/2024 (179 Days)
Parity 1 : 1
Emission price 299
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 303.6
Lowest since issue 246.6
Spread 0.06
Spread %0.02%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
252.8 CHF
Average target price
278.1 CHF
Spread / Average Target
+9.99%
Consensus